NCT00490945View on ClinicalTrials.gov

Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Circadian Rhythm Sleep Disorders
Interventions
DRUG

VEC-162

Trial Locations (2)

Unknown

Vanda Investigational Site, Boston

Vanda Investigational Site, Detroit

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY